Patent · US Active

Solid forms

US10221125B2 · kind B2 · utility

1Cited by

19References

34Claims

0Family size

Assignee

Oryzon Genomics S.A. · ES

Inventors

Ralph Diodone · Breisach am Rhein, DE
Urs Schwitter · Reinach, CH
Rene Trussardi · Basel, CH

Key dates

Filing date	May 2, 2016
Grant date	Mar 5, 2019
Priority date	—
Expiry date	May 2, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The instant invention relates to novel solid forms of the compound of formula (I) or salts thereof as well as processes for their manufacture, pharmaceutical compositions comprising them, and their use as medicaments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.